Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? have?

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? has 46 citations in the OpenAlex counts ScholarIQ stores.

When was Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? published?

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? has 2018 year in the ScholarIQ index.

What is the open-access status of Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients??

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? has hybrid oa status in the ScholarIQ index.

What is the DOI of Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients??

The DOI for Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? is on the source record.

What is the PMID of Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients??

The PMID for Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? is on the source record.

What is the OpenAlex record for Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients??

The OpenAlex for Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? is on the source record.